Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature
Descripción del Articulo
Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1:...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2010 |
| Institución: | Universidad Nacional Mayor de San Marcos |
| Repositorio: | Revistas - Universidad Nacional Mayor de San Marcos |
| Lenguaje: | español |
| OAI Identifier: | oai:ojs.csi.unmsm:article/72 |
| Enlace del recurso: | https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72 |
| Nivel de acceso: | acceso abierto |
| Materia: | Agonistas dopaminérgicos enfermedad de Parkinson trastorno de control de impulsos conducta sexual. Dopamine agonists Parkinson disease impulse control disorders sexual behavior. |
| id |
REVUNMSM_cc70d18bd3fd7894c48ba2f3bad024e2 |
|---|---|
| oai_identifier_str |
oai:ojs.csi.unmsm:article/72 |
| network_acronym_str |
REVUNMSM |
| network_name_str |
Revistas - Universidad Nacional Mayor de San Marcos |
| repository_id_str |
|
| dc.title.none.fl_str_mv |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature Hipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casos |
| title |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| spellingShingle |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature Custodio, Nilton Agonistas dopaminérgicos enfermedad de Parkinson trastorno de control de impulsos conducta sexual. Dopamine agonists Parkinson disease impulse control disorders sexual behavior. |
| title_short |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| title_full |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| title_fullStr |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| title_full_unstemmed |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| title_sort |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literature |
| dc.creator.none.fl_str_mv |
Custodio, Nilton Montesinos, Rosa Lira, David Torres, Hernando |
| author |
Custodio, Nilton |
| author_facet |
Custodio, Nilton Montesinos, Rosa Lira, David Torres, Hernando |
| author_role |
author |
| author2 |
Montesinos, Rosa Lira, David Torres, Hernando |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
Agonistas dopaminérgicos enfermedad de Parkinson trastorno de control de impulsos conducta sexual. Dopamine agonists Parkinson disease impulse control disorders sexual behavior. |
| topic |
Agonistas dopaminérgicos enfermedad de Parkinson trastorno de control de impulsos conducta sexual. Dopamine agonists Parkinson disease impulse control disorders sexual behavior. |
| description |
Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1: A 62-year-old man with PD treated with levodopa/carbidopa. He needed to start pramipexole and twelve months later he presented hypersexuality that improved with escitalopram. Case 2: A 66-year-old man with PD treated with levodopa/carbidopa, entacapone and clonazepam. He needed to start pramipexole; sixteen months later he presented hypersexuality that disappeared with escitalopram. Case 3: A 45-year-old man with Parkinsonism secondary to acute disseminated encephalomyelitis treated with risperidone, amitriptyline and clonazepam. He needed to start pramipexole; two months later, he presented hypersexuality and received escitalopram; hypersexuality disappeared only when decreasing pramipexole dose; then he started levodopa/carbidopa and hypersexuality reappeared that decreased again when reducing levodopa/carbidopa dose. Conclusions: Pramipexole may be associated with hypersexuality, but it is necessary to be careful with characteristics either related to disease or to individual factors. Hypersexuality may improve with escitalopram and its associated symptoms should be treated. |
| publishDate |
2010 |
| dc.date.none.fl_str_mv |
2010-03-15 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72 10.15381/anales.v71i1.72 |
| url |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72 |
| identifier_str_mv |
10.15381/anales.v71i1.72 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72/67 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torres https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torres https://creativecommons.org/licenses/by-nc-sa/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
| publisher.none.fl_str_mv |
Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana |
| dc.source.none.fl_str_mv |
Anales de la Facultad de Medicina; Vol. 71 No. 1 (2010); 51-3 Anales de la Facultad de Medicina; Vol. 71 Núm. 1 (2010); 51-3 1609-9419 1025-5583 reponame:Revistas - Universidad Nacional Mayor de San Marcos instname:Universidad Nacional Mayor de San Marcos instacron:UNMSM |
| instname_str |
Universidad Nacional Mayor de San Marcos |
| instacron_str |
UNMSM |
| institution |
UNMSM |
| reponame_str |
Revistas - Universidad Nacional Mayor de San Marcos |
| collection |
Revistas - Universidad Nacional Mayor de San Marcos |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1795238239508889600 |
| spelling |
Hypersexuality associated to pramipexole in the treatment of parkinsonian symptoms: presentation of 3 cases and review of the literatureHipersexualidad asociada a pramipexol, en el tratamiento de síntomas parkinsonianos: revisión de la literatura, a propósito de 3 casosCustodio, NiltonMontesinos, RosaLira, DavidTorres, HernandoAgonistas dopaminérgicosenfermedad de Parkinsontrastorno de control de impulsosconducta sexual.Dopamine agonistsParkinson diseaseimpulse control disorderssexual behavior.Introduction: Impulse control disorders have been reported in patients with Parkinson’s disease (PD), and in users of dopamine agonists. We report three cases of patients with parkinsonian symptoms and hypersexuality, an impulse control disorder associated with pramipexole use. Case reports: Case 1: A 62-year-old man with PD treated with levodopa/carbidopa. He needed to start pramipexole and twelve months later he presented hypersexuality that improved with escitalopram. Case 2: A 66-year-old man with PD treated with levodopa/carbidopa, entacapone and clonazepam. He needed to start pramipexole; sixteen months later he presented hypersexuality that disappeared with escitalopram. Case 3: A 45-year-old man with Parkinsonism secondary to acute disseminated encephalomyelitis treated with risperidone, amitriptyline and clonazepam. He needed to start pramipexole; two months later, he presented hypersexuality and received escitalopram; hypersexuality disappeared only when decreasing pramipexole dose; then he started levodopa/carbidopa and hypersexuality reappeared that decreased again when reducing levodopa/carbidopa dose. Conclusions: Pramipexole may be associated with hypersexuality, but it is necessary to be careful with characteristics either related to disease or to individual factors. Hypersexuality may improve with escitalopram and its associated symptoms should be treated.Introducción: Los desórdenes del control de los impulsos han sido reportados en pacientes con enfermedad de Parkinson (EP), así como en usuarios de agonistas dopaminérgicos. Comunicamos tres casos de pacientes con síntomas parkinsonianos e hipersexualidad, un desorden del control de los impulsos, asociado al uso de pramipexol. Casos clínicos: Caso 1: Varón de 62 años de edad con EP en tratamiento con levodopa/carbidopa, que requirió inicio de pramipexol; a los doce meses presentó hipersexualidad que remitió parcialmente con escitalopram. Caso 2: Varón de 66 años de edad con EP en tratamiento con levodopa/carbidopa, entacapona y clonazepam; requirió inicio de pramipexol y a los dieciséis meses presentó hipersexualidad, que remitió totalmente con escitalopram. Caso 3: Varón de 45 años de edad con parkinsonismo secundario a encefalitis esclerosante aguda en tratamiento con risperidona, amitriptilina y clonazepam; requirió inicio de pramipexol; a los dos meses presentó hipersexualidad, recibió escitalopram, pero la hipersexualidad solo desapareció al disminuir la dosis de pramipexol; se inició levodopa/carbidopa y reapareció la hipersexualidad, que desapareció con la disminución de la dosis de levodopa/carbidopa. Conclusiones: Pramipexol podría estar asociado a hipersexualidad; pero, es necesario tener en cuenta las características relacionadas a cada enfermedad, así como los factores individuales. La hipersexualidad podría mejorar con el escitalopram, siendo necesario tratar los síntomas asociados.Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana2010-03-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/7210.15381/anales.v71i1.72Anales de la Facultad de Medicina; Vol. 71 No. 1 (2010); 51-3Anales de la Facultad de Medicina; Vol. 71 Núm. 1 (2010); 51-31609-94191025-5583reponame:Revistas - Universidad Nacional Mayor de San Marcosinstname:Universidad Nacional Mayor de San Marcosinstacron:UNMSMspahttps://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/72/67Derechos de autor 2010 Nilton Custodio, Rosa Montesinos, David Lira, Hernando Torreshttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessoai:ojs.csi.unmsm:article/722020-04-15T17:40:35Z |
| score |
13.888049 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).